Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-15

FDA Approved: EXEMESTANE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Exemestane submitted by Mylan Pharmaceuticals Inc. The action involves approval of changes to the product labeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exemestane (Exemestane)

Snippet

SUPPL AP for EXEMESTANE (EXEMESTANE)